Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Gilead Sciences, Inc. (GILD) had Receiveable Turnover of 1.61 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$7.92B |
|
$2.18B |
|
$1.62B |
|
$6.30B |
|
$5.94B |
|
$1.98B |
|
$95.00M |
|
$2.08B |
|
$2.08B |
|
$2.18B |
|
$2.18B |
|
$2.18B |
|
$2.18B |
|
$1.98B |
|
$2.67B |
|
1.24B |
|
1.25B |
|
$1.75 |
|
$1.75 |
|
| Balance Sheet Financials | |
$18.34B |
|
$5.61B |
|
$40.68B |
|
$59.02B |
|
$11.81B |
|
$22.13B |
|
$24.59B |
|
$36.41B |
|
$22.62B |
|
$-2.67B |
|
$22.62B |
|
1.24B |
|
| Cash Flow Statement Financials | |
$10.02B |
|
$-4.79B |
|
$-7.75B |
|
$9.99B |
|
$7.56B |
|
$-2.43B |
|
$894.00M |
|
$-4.00B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.55 |
|
-- |
|
-- |
|
0.49 |
|
1.10 |
|
79.51% |
|
25.03% |
|
25.03% |
|
-- |
|
26.21% |
|
27.55% |
|
$9.46B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.92 |
|
|
Receiveable Turnover |
1.61 |
55.79 |
|
9.65% |
|
-81.60% |
|
3.70% |
|
4.88% |
|
$18.23 |
|
$7.53 |
|
$7.98 |
|